Natural Killer (Nk) Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Natural Killer (NK) cells are innate lymphoid cells that provide rapid cytotoxic responses against stressed, infected, or malignant cells without prior sensitization. They bridge innate and adaptive immunity and have emerging roles in neuroimmune interactions relevant to neurodegeneration.
NK cells are large granular lymphocytes derived from common lymphoid progenitors in bone marrow. They constitute 5-15% of peripheral blood lymphocytes and are found in various tissues including spleen, liver, and uterine decidua.
- CD56 (NCAM1) - major NK cell marker
- CD16 (FcγRIIIa) - antibody-dependent cellular cytotoxicity
- CD94 - NK cell receptor complex
- NKG2A/C/D/E - C-type lectin receptors
- KIRs (KIR2DL, KIR3DL) - killer cell immunoglobulin-like receptors
- CD56bright CD16dim - cytokine producers, regulatory
- CD56dim CD16bright - cytotoxic effectors
- CD56neg CD16pos - adaptive-like NK cells
- Perforin delivery to target cells
- Granzymes (A, B, K) induce apoptosis
- Fast acting (minutes)
- NKG2D engagement (stress ligands)
- Death receptor pathways (Fas/TRAIL)
- Antibody-dependent cellular cytotoxicity (ADCC)
- IFN-γ - antiviral, immunomodulatory
- TNF-α - pro-inflammatory
- IL-10 - anti-inflammatory
- GM-CSF - myelopoiesis
- CCL3/MIP-1α - chemotaxis
- Interaction with dendritic cells
- Modulation of adaptive immunity
- Clearance of stressed cells
- Reduced NK cell cytotoxicity in AD patients
- Altered NKG2D expression
- Impaired IFN-γ production
- Correlation with disease severity
- NK cells found in AD brain vasculature
- Perivascular NK cell accumulation
- Interaction with blood-brain barrier
- NK cell modulation strategies
- Enhancing immune surveillance
- Targeting stress-induced ligands
- Decreased NK cell numbers in PD
- Impaired cytotoxicity against α-synuclein targets
- Altered KIR repertoire
- Correlation with motor symptoms
- NK cells can kill α-synuclein-expressing cells
- NKG2D recognizes stressed dopamine neurons
- Potential for immune clearance
- Protective: antiviral activity, immune surveillance
- Pathogenic: may attack CNS cells
- MS therapies affect NK cell function
- NK cell counts predict relapse risk
- Interferon-β increases NK cell activity
- Natalizumab modulates NK cell trafficking
¶ Stroke and Brain Injury
- NK cells infiltrate damaged brain
- Acute phase: pro-inflammatory
- Subacute phase: regulatory functions
- Clearance of dead cells
- Prevention of autoimmunity
- Promotion of repair
- NK cells can cross BBB under inflammation
- Regulation of BBB permeability
- Interaction with endothelial cells
- NKG2D ligands on stressed neurons
- MICA/B expression in neurodegeneration
- ULBP proteins in CNS pathology
- NK cells regulate microglia activation
- Cross-talk via cytokines
- Coordinated immune responses
- IL-15 therapy - NK cell expansion
- KIR mismatching - enhanced alloreactivity
- CAR-NK cells - targeted killing
- NKG2D antagonists
- KIR blockade
- Cytokine modulation
| Drug |
Effect on NK Cells |
| Interferon-α |
Activation |
| Glatiramer acetate |
Modulation |
| Fingolimod |
Sequestration |
| Dimethyl fumarate |
Alteration |
The study of Natural Killer (Nk) Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhang Y, et al. Natural killer cells in Alzheimer's disease. J Neuroinflammation. 2022
- Earls RH, et al. NK cells in Parkinson's disease. Nat Rev Neurol. 2020
- Mandybur TI, et al. NK cells in multiple sclerosis. Neurology. 2021
- Zhang W, et al. NKG2D and neurodegeneration. Trends Neurosci. 2023
- Liu Q, et al. NK cell-based immunotherapy for neurodegenerative diseases. Cell Mol Immunol. 2021
- Morandi E, et al. NK cells in CNS autoimmunity. Nat Rev Neurosci. 2022